Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum by unknown
ISOLATION OF A LIPOPOLYSACCHARIDE-BINDING ACUTE
PHASE REACTANT FROM RABBIT SERUM
BY PETER S. TOBIAS, KATRIN SOLDAU, AND RICHARD J. ULEVITCH
From the Department ofImmunology, Scripps Clinic and Research Foundation,
La Jolla, California 92037
We have reported that human, murine, and lapine acute phase sera differ
functionally from the respective normal sera in at least three ways (1, 2), insofar
as interactions with bacterial LPS are concerned. First, the rate at which LPS
binds to high density lipoprotein (HDL)' is much faster in normal sera than in
acute phase sera. For example, in normal sera, the half time for binding of
Salmonella minnesota Re595 LPS to HDL at 37°C is typically 2-3 min, whereas
in acute phase sera, the same reaction can have a half time of up to 100 min.
Second, when Re595 LPS is added to serum and spun to equilibrium in a CsCl
density gradient, the LPS not bound to HDL is found at a density of 1 .33 g/cm3
in normal sera, whereas in acute phase sera the LPS forms a complex with a
density of 1.3 g/cm 3. We refer to the form of LPS in acute phase serum as
complex 1.3 (C.1 .3). Finally, when sera containing LPS not yet bound to HDL
are chilled rapidly to 4°C and dialysed against very low ionic strength buffer at
4°C an LPS-protein precipitate is formed from both normal and acute phase
sera, but the LPS in the precipitate from normal serum redissolves readily in
isotonic saline, while the LPS in the precipitate from acute phase serum does
not. These phenomena have been seen after acute phase induction with either
subcutaneous silver nitrate, intraperitoneal LPS, or casein (unpublished data).
We have postulated the existence ofahithertounrecognized acutephase reactant
to explain these findings.
In this report, a purification of the acute phase reactant from acute phase
rabbit serum (APRS) responsible for the phenomena noted above is described,
as are some ofthe properties of the reactant. As shown by experiments reported
herein, the acute phase reactant does bind directly to LPS; therefore, we refer
to it as LPS-binding protein, or LBP.
Materials and Methods
Materials.
￿
Biosynthetically tritiated LPS ([3H]LPS) and unlabeled LPS were isolated
from Salmonella minnesota Re595as describedpreviously (2, 3). Rabbit bloodwascollected
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either by bleeding from the median ear artery or by heart puncture, allowed to clot at
37°C for 2-6 h and at 0°C overnight, centrifuged to remove clot fragments and cells,
and the serum was stored frozen without preservative. APRS was collected 24 h after
induction of an acute phase response by subcutaneous injection of I ml of 3% (wt/vol)
silver nitrate in distilled water. Serum collected from noninduced rabbits was tested for
normality before being used as normal rabbit serum (NRS). The initial test used was
immunodiffusion vs. antiserum to rabbit C-reactive protein (CRP). Sera testing negative
for CRP were further tested, by methods described below, to ensure a sufficiently rapid
rate of binding of LPS to HDL . These precautions were instituted after observing that as
many as one-half of newly acquired New Zealand White rabbits typically have detectable
acute phase reactants in their sera .
Polyclonal rat antisera to LBP were raised in Lewis rats by intraperitoneal injection of
each rat with 25 Fcg LBP in CFA, with 25 kg LBP in IFA at 3 wk, and with 10 tag LBP in
buffer at 6 wk. Animals were bled by heart puncture under Innovar-Vet anesthesia and
serum collected as described above. Immunoprecipitation experiments using these sera
were performed by incubating rabbit serum together with varying volumes of antiserum
for at least 3 h at 37°C or 4 h at 4 ° C. Precipitates were collected by centrifugation and
washed twice with 50 mM phosphate buffer, 150 mM NaCl, and 0 .1% Tween-20 (pH
7.4).
Unfractionated lipoproteins and delipoproteinated sera were prepared by ultracentrif-
ugation. We added 13.23 g KBr to 35 ml serum, after which the serum was spun at
40,000 rpm in a 60 Ti (Beckman Instruments, Inc ., Fullerton, CA) rotor for 36-60 h at
4°C. After fractionation, protein assay, and cholesterol assay (Cal Biochem-Behring, La
Jolla, CA), the lipoproteins and serum proteins were separately pooled and dialysed
extensively against 10 mM Hepes and 150 mM NaCl (pH 7.4). Finally, the delipoprotein-
ated sera and the lipoproteins were brought to 75 and 25% of the original serum volume,
respectively, by dilution or concentration, as required. Delipoproteinated sera and lipo-
proteins were recombined in a 3 :1 ratio, respectively, to prepare lipoprotein-reconstituted
sera.
LPS was coupled to sulfosuccinimidyl-2-(p-azido salicylamido)-1,3'-dithiopropionate
(Pierce Chemical Co., Rockford, IL.) as described (4), and the resulting derivative (ASD-
LPS) was radiolabeled with Na'25I using chloramine T (5) to yield ' SI-ASD-LPS. The
product had a specific activity of 7.1 x 109 cpm/mg LPS, from which the incorporation
of "I into LPS is calculated to be -0.3 mot %. Unpublished data indicate that '-51-ASD-
LPS cosediments with LPS in CsCl gradients, "5I-ASD-LPS is quantitatively taken up by
HDL in NRS or APRS, and ASD-LPS has the same mitogenicity as LPS when tested with
murine splenic B cells. Photolysis of ' 25I-ASD-LPS was accomplished using a Rayonet
photochemical reactor (Southern N .E. Ultraviolet Co., Middletown, CT) equipped with
General Electric F8T5.BLB lamps with peak output at 370 rim. Reaction mixtures were
exposed to this light source for 10 min at 4°C.
Methods.
￿
SDS-PAGE with staining by Coomassie Blue or periodic acid/Schiff reagent
was performed by published procedures (6). Samples were reduced with 2-ME before
SDS-PAGE, and gels contained 10% acrylamide. Concentrations of LPS and its derivatives
were determined using the ketodeoxyoctanoate assay (7), with Re595 LPS as standard .
Protein concentrations were determined by either the Folin (8) or BCA (Pierce Chemical
Co.) reagents, using BSA as standard. All reactions of LPS or LPS derivatives with APRS
or NRS were carried out at 10 jag/ml, unless otherwise noted.
Amino acid sequencing was carried out by the Protein Structure Core Laboratory of
Scripps Research Foundation according to published procedures (9).
Kinetics ofLPS Binding to HDL.
￿
The kinetics of LPS binding to HDL in serum were
observed and quantitated by CsCl isopycnic density gradient ultracentrifugation . We
added 0.4 ml of 0.4 M EDTA (pH 7.4) to 8 ml of rabbit serum, and warmed the mixture
to 37°C in a water bath . At time 0, 0.4 ml of 200 tag/ml [sH]LPS in 0 .02 M EDTA, pH
7 .4, was added. At suitable times, 1 .0-ml aliquots of the reaction mixture were removed
and added to 3.8 ml of ice-cold 2.81 M CsCI, 0 .15 M NaCl. These samples were thenTOBIAS ET AL. 779
spun to equilibrium for 16 h at 45,000 rpm in a TV-865 rotor (DuPont Co., Wilmington,
DE) at 0-4'C. After centrifugation, the gradients were fractionated, the refractive index
was measured if the density profile of the gradient was to be determined, and the [sH]-
LPS in each fraction was determined by liquid scintillation counting. The efficiency of
measuring [sH]LPS was independent of the amount of CsCl in each vial. After graphing
the [sH]LPS profile for each gradient, the amount of radioactivity in the body of the
gradient, i.e., not bound to the HDL that floats at the top of the gradient, was calculated
as a percentage of the radioactivity recovered in the entire gradient. A logarithmic plot
of this percentageas a function of the time of removal of the aliquot from the LPS serum
reaction mixture yielded the t.,, for the binding of LPS to HDL.
Reconstitution Assayfor LBP Activity.
￿
The basic method used during development of
the purification procedure for LBP was a reconstitution assay in which fractions of acute
phase serum were tested for their ability to reconstitute acute phase behavior in NRS.
For a screening assay we mixed a sample of the material to be tested with 1 .0 ml of NRS
at 37°C for 30 min. ["H]LPS and EDTA were then added to 10 wg/ml and 20 mM,
respectively, and the LPS-HDL binding reaction was allowed to proceed for 10 min at
37°C before addition of CsCl and centrifugation. The 10 min reaction time was chosen
as a compromise between the times required for LPS to bind to HDL in NRS and APRS.
Observation of a peak of [sH]LPS at a density of 1 .30 g/cms signaled the presence of LBP
activity . To more quantitatively assay LBP activity, we performed the reconstitution assay
just described by assaying a series of different amounts of the sample, up to a maximum
of 200 ul per ml NRS. After centrifugation and quantitation of the LPS in C.1 .3, a plot
of percent LPS as C.1 .3 vs. log (sample volume) was made . One LBP unit is defined as
that amount of LBP activity that causes 50% of the recovered LPS to be recovered as
C.1 .3 after 10 min. at 37 ° C. LBP activity in APRS was assayed similarly, except that the
final volume of the NRS-APRS mixture was held constant and the final plot was then
percent LPS as C .1 .3 vs. log (percent APRS).
Purification of LBP.
￿
Two chromatographic procedures make up the purification pro-
cedure for LBP. Serum was first fractionated using Bio Rex-70 resin (Bio-Rad Laborato-
ries, Richmond, CA). 50 ml of resin was equilibrated with 41 mM NaCl in 50 mM
phosphate buffer, pH 7 .3, containing 2 mM EDTA (phosphate/EDTA). 400 ml of APRS,
containing 5 mM EDTA, was run over the column at ^-65 ml/h. The column was then
washed with column equilibration buffer overnight or until the absorbance (280 nm) of
the eluate was <0.2 absorbance units (AU) . Washing was continued with 220 mM NaCl
in phosphate/EDTA, again until the absorbance was <0.2; this was followed by a linear
gradient, formed from 60 ml each of 220 mM and 500 mM NaCl in phosphate/EDTA.
Finally, the column was washed with 1 M NaCl in phosphate/EDTA. Pools of fractions to
be tested for LBP activity were dialysed vs. 5 mM Hepes, pH 7 .3, concentrated to 6 ml
using PTGC (Millipore, Bedford, MA) or YM10 (Amicon Corp., Danvers, MA) mem-
branes in an Amicon ultrafiltration cell, and any precipitate was removed by centrifuga-
tion. The second chromatographic step used HPLC (Perkin-Elmer Corp., Norwalk, CT),
with a Mono-Q column (Pharmacia, Piscataway, NJ) as the adsorbent. Unless otherwise
noted, the flow rate was 1 ml per minute. The column was equilibrated with 2 mM
diethanolamine buffer, pH 8 .3. Injection of the sample was followed immediately by a 15
ml gradient of 0-50 mM ammonium sulfate in 20 mM diethanolamine, pH 8.3. The
gradient was then steepened, going in 15 ml from 50-333 mM ammonium sulfate in the
same buffer. Finally the column was washed for 5 min at a flow rate of 2 ml per min with
333 mM ammonium sulfate, again in 20 mM diethanolamine, pH 8.3 . Fractions were
collected and, on the basis of the absorbance profile of the column eluate, pooled into
three pools, dialysed against 5 mM Hepes buffer (pH 7 .4), and concentrated to 2 ml.
Final separation of the last two components of the LBP-containing fractions from
Mono-Q chromatography was accomplished by SDS-PAGE. After electrophoresis and
light staining with Coomassie Blue, the protein bands were cut apart and recovered from
the gel by electroelution (10).780
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￿
Examples of the NRS reconstitution assay for LBP activity . Percent of APRS in
NRS (O) or reconstitution ofNRS with LBP (Al ; 0) . See text for details .
Results
NRS Reconstitution Assay .
￿
Two examples of the NRS reconstitution assay for
LBP activity are shown in Fig . 1 . In control experiments, no systematic depend-
ence on the assay results was observed when smaller total assay volumes, i .e ., 0 .5
or 0.25 ml rather than the standard I ml, were used . Reproducibility of the assay
was±20% .
Purification ofLBP.
￿
Since LPS added to serum forms a complex with HDL,
we determined whether an initial separation of the lipoproteins from APRS
would be a useful first purification step . Mixing lipoproteins prepared from NRS
or APRS with delipoproteinated NRS or APRS provided reconstituted sera with
alternate sources of lipoproteins . As shown in Fig . 2, C .1 .3 formed only when
delipoproteinated APRS was used, and was independent of the source of the
lipoproteins used to form the reconstituted serum . Therefore, we turned to
whole serum as the starting material for LBP isolation .
Chromatography ofAPRS on Bio-Rex 70 proved to be a very effective initial
step in purification of LBP. The absorbance profile of APRS or NRS passed
over the column, as well as the fractions pooled for analysis, is shown in Fig. 3.
When 400 ml APRS was passed over a 50-ml bed of Bio-Rex 70, the ability to
form C.1 .3 was largely removed. This can be seen in Fig . 4, where CsCl density
gradient tests of the ability of the various pools to reconstitute NRS are shown,
as are tests of the nonabsorbed proteins (flow-through) . LBP activity was eluted
only at salt concentrations above 300 mM NaCI, with the largest amount eluting
in the 1 M NaCl wash, i .e ., pool C, Fig . 4. Washing the column with 3M NaCl
did not elute more LBP activity . Assay results for the three pools eluted from
the Bio Rex-70 column are shown for a typical preparation of LBP (Table 1) .
Overall, i.e ., combining pools A, B, and C, some 32% of the LBP activity was
recovered for an increase in specific activity of 927-fold by Bio-Rex 70 chroma-
tography . When NRS rather than APRS was chromatographed on the same
column, an almost identical protein elution profile was obtained, as shown inE c
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￿
CsCI density gradient analyses for C.1 .3 formation in delipoproteinated APRS
(A)or delipoproteinated NRS (B) reconstituted with lipoproteins from NRS (/) or APRS (p).
-30
v
i i rri i i~-0
60 60 100 120 140
Fraction Number
0
L
E
a
V
FIGURE 3.
￿
Ion exchange chromatography on Bio-Rex 70 resin of APRS (A) or NRS (B).
Fractions pooled are denoted by the horizontal lines and letters within the graph. Solid lines,
absorbance at 280 nm; broken lines, conductivity.
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Fig. 3B, but none of the pooled fractions had any significant LBP activity (Fig.
4). SDS-PAGE gels of the "C" pools from APRS and NRS are shown in Fig. 5,
lanes 3 and 6, respectively.
Further purification of LBP was accomplished with HPLC using a Mono-Q782
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￿
CsCI density gradient analyses of LBP activity in pools from Bio-Rex 70 chro-
matography ofAPRS (left panels) or NRS (right panels) . Pools tested for activity are identified
in Fig . 3 . Not all gradients yielded exactly the same number of fractions. Thus, the abscissa
normalized fraction position is used to standardize display of the gradients. A value of 0
represents the bottom of the gradient ; I represents the top of the gradient .
column . When an aliquot of pool C from Bio-Rex 70 chromatography of NRS
or APRS was run on the Mono-Q column and eluted with a gradient of
ammonium sulphate, the absorbance profile of the eluate was as shown in Fig .
6 . The profile obtained with Bio-Rex 70 pool C derived from APRS shows a
peak eluting near ^-20 min not seen in the profile obtained with pool C derived
from NRS. Fractions containing the unique APRS-derived peak, as well as the
analogous fractions from the NRS material, were assayed for LBP activity. As
shown in Fig. 7, the unique protein peak from APRS does show LBP activity .
All other fractions tested had no LBP activity . After pooling, dialysis, and
concentration, 33% of the activity applied to the Mono-Q column was recovered,
with a twofold increase in specific activity (see Table 1) . An SDS-PAGE gel of
the LBP-containing peak is shown in Fig . 5, lane 8 . From the mobilities of the
two bands in lane 8, relative to the standards in lane 9, the apparent masses of
the two proteins are 60 .5 and 58 kD . Judging by staining intensity, the 60.5-kD
band usually makes up 90% of the mixture, but has varied between 85 and95% .
Final resolution of the two proteins present in the active pool from Mono-Q
chromatography was accomplished by SDS-PAGE, then slicing the two bands
apart after staining, and recovering the proteins by electroelution . The separa-
tion of the two bands is shown in Fig . 8 . Amino acid sequence data, described
below, suggest that both bands have very similar primary structures ; this arguesTABLE I
Purification ofLBP
TOBIAS ET AL .
Purification of pool C through HPLC : 2,307-fold
Overall purification : 1,982-fold
FIGURE 5 .
￿
SDS-PAGE analyses of chromatography fractions . Lanes 1, 2, and 3are pools A,
B, and C, respectively, from Bio-Rex 70 chromatography of APRS . Lanes 4, 5, and 6 are
pools A, B, and C, respectively, from Bio-Rex 70 chromatography ofNRS. Lane 7, molecular
mass markers : 94, 67, 43, 30, and 20 .1 kD . Lane 8, 20-min fraction from Mono-Q chroma-
tography of pool C, APRS . Lane 9, molecularmass markers : 94, 67, 43, and 30 kD .
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Fraction
Volume
MI
LBP
Activity
U/ml
Protein
mg/ml
Sp Act
U/mg
Total
activity
U
Total protein
mg
Starting material
APRS 400 2.8 70 0.04 1,120 28,000
Bio-Rex-70 pools
A 6 13.9 0.65 21 .4 83 3.93
B 6 14.3 0.45 31 .8 86 2.73
C 6 32.9 0.54 60.9 197 3.21
Combined results 37 .1 366 9.87
Overall purification : 927-fold
HPLC of Bio-Rex Pools
A 2 4.6 0.12 38.3 9.2 0.24
B 2 15 .1 0.20 75 .5 30.2 0.40
C 2 40.6 0.44 92.3 81 .2 0.88
Combined results 79.3 120.6 1 .52784 LIPOPOLYSACCHARIDE-BINDING ACUTE PHASE REACTANT
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FIGURE 6 .
￿
Ion exchange chromatography on Mono-Q resin of pool C from Bio-Rex 70
chromatography of APRS (A) or NRS (B) . Solid lines, absorbance at 280 nm ; broken lines,
molarity of ammonium sulfate (1 ml fractions) .
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FIGURE 7 .
￿
CsCl density gradient analyses ofLBP activity in fractions eluting at 20 min from
Mono-Q chromatography, as shown in Fig . 6 . (A) Fractions collected from APRS ; (B) fractions
collected from NRS .
that both bands may be LBP . Both bands stain with periodic acid/Schiffreagent,
thus they are both glycoproteins .
From the LBP-specific activities for APRS and the purest isolated LBP, the
concentration ofLBP in APRS is found to be 30-35 Ag/ml .
Amino Acid Sequence Data .
￿
Partial amino acid sequence data were obtained
for two preparations of LBP, the mixture of 60 .5 and 58 kD proteins obtained
from Mono-Q chromatography, and the 58 kD minor component purified by
SDS-PAGE . Initially, material collected from Mono-Q chromatography was
sequenced. Since this material consists of 85-90% of the 60.5-kD protein, these
data reflect the sequence of the major component recovered from the column .
The amino acid sequence of the first 39 amino acids from the N-terminus is
shown in Fig . 9. With the exception of positions 1, 36, 38, and 39, all positions
were determined in duplicate for two different preparations . Positions 1, 36, 38,
A AMS 0 .4
E 0 .2
0 y
Q B MS 0 .4 >
0
0 .2TOBIAS ET AL .
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FIGURE 8 .
￿
SDS-PAGE analysis of the 58,000 (lane 1) and 60,500 (lane 3) mol wt bands,
separated electrophoretically from the mixture (lane 2) obtained after Mono-Q chromatogra-
phy . See text for details.
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Gly-Leu-Leu-Ala-Leu-Gln-Arg-Lys-Leu-XXX-
31
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39
Gly-Val-Thr-Leu-Pro-Asp-Phe-Asp-Gly
FIGURE 9 .
￿
Partialamino acid sequence for two preparations of LBP .
and 39 were identifiable in only one run of the sequenator . Position 30 did not
yield an identifiable residue and may represent a site of glycosylation . Sequence
data for the 58-kD minor protein was obtained for 36 residues . The sequence of
the 58-kD protein agreed completely with that of the mixture of proteins, even
to the indeterminate residue 30 (Fig . 9) .
The 39 amino acid sequence was used to search for homologous sequences in
the National Biomedical Research Foundation protein sequence database ; we
used the Wordsearch program from the University ofWisconsin Genetics Com-
puter Group (Madison, WI) . This procedure resulted in two matches: to se-
quences (Fig . 10) from human influenza virus b hemagglutinin precursor (11)
and baker's yeast glyceraldehyde 3-phosphate dehydrogenase (12) . We also used786
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FIGURE 10 .
￿
Amino acid sequence homologies found for LBP with human influenza virus b
hemaglutinin precursor or baker's yeast glyceraldehyde-3-phosphate dehydrogenase .
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FIGURE 11 .
￿
CsCl density gradient analysis for LBP activity of immunoprecipitate superna-
tants obtained from mixtures of APRS or NRS and rat anti-LBP antiserum . APRS, no
antiserum (O) ; APRS, 1 .7% (vol/vol) antiserum (A) ; APRS, 4.6% (vol/vol) antiserum (p) ;
APRS, 14% (vol/vol) antiserum (Q) ; NRS, 14% (vol/vol) antiserum (0) .
Wordsearch to look for homology between the sequences of LBP and rabbit
CRP (13), human serum amyloid P (14), human serum amyloid a (15), syrian
hamster female acute phase protein (16), human a-l-antichymotrypsin precursor
(17), human a-1 acid glycoprotein (18), and the major acute phase a-1 glycopro-
tein of the rat (19) . No significant homology was found with any of these acute
phase reactants .
Depletion ofAPRS with RatPolyclonal Anti-LBP.
￿
When examined by Ouchter-
lony gel diffusion, rat antisera were reactive with APRS- and LBP-containing
fractions of APRS isolated by Bio Rex-70 and Mono-Q columns, but not with
NRS or NRS fractions corresponding to the fractions isolated from APRS (data
not shown) . The antisera were then tested for their ability to immunoprecipitate
LBP and simultaneously remove LBP activity from APRS . In these experiments,
both NRS and APRS were mixed with immune and nonimmune rat sera . After
precipitation the supernates were collected to determine their ability to form
C.1 .3 (Fig . 11), indicating the presence or absence of LBP activity, and the
precipitates were saved for analysis by SDS-PAGE (Fig . 12) . When the superna-
tants from the immunoprecipitates were tested for their ability to form C.1 .3,
the amount of C.1 .3 seen was inversely proportional to the amount of immune
serum added to theAPRS (Fig . 11). Rat sera, immune or not, did not inhibit the
binding of [3HJLPS to HDL in NRS. When the constituent proteins of the
immunoprecipitate were visualized by SDS-PAGE, only the mixtures ofimmune
rat serum reacted with APRS yielded significant immunoprecipitates with bands
5 LITRITDKGLEYAAREGLLALQRKLXGVTLP 35 LBP
I I I IIII III I
459 LAVLLSNEGIINSEDEHLLALERKLKKMLGP 489 INFLUENZA
8 RITDKGLEYAAREGL.LALQRKLXGV 32 LBP
II I I 1111111 1
2 RIAINGFGRIGRLVLRLALQRKDIEV 27 BAKER'S YEASTTOBIAS ET AL .
FIGURE 12 .
￿
SDS-PAGE analyses of immunoprecipitates obtained from APRS or NRS and
anti-LBP antisera . Lane 1, molecular mass (94, 62, 43, and 30 kD) markers; lane 2, NRS plus
14% (vol/vol) preimmune serum ; lane 3, NRS plus 14% (vol/vol) antiserum ; lane 4, APRS
plus 14% (vol/vol) preimmune serum; lane 5, APRS plus 14% (vol/vol) antiserum ; lane 6,
APRS plus 4.6% (vol/vol) antiserum ; lane 7, APRS plus 1.7% (vol/vol) antiserum ; lane 8,
APRS plus 0.6% (vol/vol) antiserum ; lane 9, purified LBP.
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corresponding to LBP (Fig. 12, lanes 5-7) . The intensity of the LBP band in the
immunoprecipitates correlated positively with the amount of immune serum
added (Fig . 12, lanes 5-8), and it correlated negatively with the ability of the
residual supernatant to form C.1 .3 (see Figure 11) . Bands other than LBP
observed in the immunoprecipitates are attributable to rat albumin and rat heavy
and light Ig chains . The combination of NRS with immune rat serum did yield
very weak bands corresponding to rat Ig chains, presumably due to a minor
contaminating specificity, (Figure 12, lane 3) . Nonimmune rat serum reacted
with either NRS or APRS yielded only bands corresponding to albumin (Figure
12, lanes 2 and 4) . Thus immunoprecipitation of LBP from APRS decreased the
ability ofAPRS to form C.1 .3 in a dose-dependent manner .
Interaction of LPS with LBP.
￿
Two types of experiments were performed to
determine whether LPS and LBP interact directly : immunoprecipitation of
[3H]LPS APRS in APRS as C.1 .3 by anti-LBP sera, and delivery of ' 25 1 to LBP
by photolysis of ' 251-ASD-LPS in APRS as C.1 .3 .
In the immunoprecipitation experiments, [3H]LPS and APRS (or NRS) were
allowed to react at 37 °C for 10 min and then were cooled to 0 °C before rat
anti-LBP was added . Unpublished data on the temperature dependence of LPS
binding to HDL show that cooling to 4°C effectively stops the formation ofLPS-
HDL complexes . The [3H]LPS content of a portion of the immunoprecipitate788
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FIGURE 13 . SDS-PAGE analyses of and quantitation of [sH]LPS in immunoprecipitates
obtained from mixtures of APRS or NRS and anti-LBP antisera. Reaction mixtures and
[sH]LPS precipitation shown below SDS-PAGE gel lanes . Lane 6, CRP .
was determined by liquid scintillation counting, while the remainder of the
precipitate was taken for SDS-PAGE . Since LPS may bind nonspecifically to
immune precipitates (20), immunoprecipitation of rabbit CRP from APRS by
goat anti-CRP in the presence of 3H-LPS was used as a control experiment . The
SDS-PAGE analysis of the immunoprecipitates is shown in Fig . 13, together with
the data for 3H-LPS recovered with the immunoprecipitate . The results show a
clear positive correlation between LBP precipitation and [3H]LPS precipitation .
However, in some control experiments as much as 25% of the 3H-LPS was
associated with the CRP-anti-CRP precipitate .
Further evidence for interaction of LPS with LBP was obtained through the
use of 1251-ASD-LPS . APRS (or NRS) was allowed to react with ' 251-ASD-LPS
for 5 min at 37°C in the dark, chilled to stop further transfer to HDL, and
photolysed . Anti-LBP antiserum was then added to collect LBP for SDS-PAGE
and autoradiographic analysis . The results for this experiment and the control
experiments are presented in Fig . 14 . Lane 1 shows that 1251-ASD-LPS photolysed
in 20 mM EDTA and 150 mM NaCl (pH 7 .4) does not yield a Coomassie Blue-
stainable band (lane 1 a), and the 1251 runs with the dye front (lane 1 b) . Lanes 2
and 3 show that 1251-ASD-LPS mixed with immunopurified rabbit anti-LPS IgG
(21) labels Ig heavy chains if photolysed after mixing (lane 3), but only veryTOBIAS ET AL .
￿
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FIGURE 14 .
￿
SDS-PAGE analysis of 'Y5I-ASD-LPS reaction mixtures. Lanes 1-3 are samples
of the reaction mixtures applied directly to the gel . Lanes 4-7 are immunoprecipitates of the
reaction mixtures precipitated with 14% (vol/vol) anti-LBP antiserum. Each pair of lanes, a
and b, represents the CoomassieBlue-stained gel andthe autoradiographic print, respectively .
Lane 1, "I-ASD-LPS ; lane 2, prephotolysed 1251-ASD-LPS with immunopurified anti-LPS ;
lane 3, "'I-ASD-LPS photolysed with immunopurified anti-LPS; lane 4, prephotolysed 'Y 51-
ASD-LPS with NRS; lane 5, 12.11-ASD-LPS photolysed with NRS; lane 6, prephotolysed 'Y5I-
ASD-LPS with APRS ; lane 7, "'I-ASD-LPS with APRS ; lane 8, molecular mass markers : 94,
43, 30, and 20 .1 kD .
weakly if also photolysed before mixing (lane 2) . For lanes 1-3, aliquots of the
reaction mixtures were applied directly to the gels . For lanes 4-7, the reaction
mixtures were immunoprecipitated with anti-LBP before application to the gel .
Lanes 4 and 5 shows that 125I-ASD-LPS, whether photolysed only after mixture
with NRS (lane 5) or also photolysed before mixture with NRS did not label any
material immunoprecipitable with anti-LBP (i.e ., lanes 4b and 5b are clear) .
Lanes 6 and 7 show that ' 25I-ASD-LPS mixed with APRS labels LBP strongly if
photolysed after mixing with APRS (lane 7), but labels LBP only weakly if also
photolysed before mixing with APRS (lane 6) .
Discussion
Purification of LBP .
￿
The two-step procedure for purification of LBP from
APRS results in a 2,300-fold purification with a yield of 10% of the initial LBP
activity . While the product is a mixture of two peptides, the peptides appear to
be very closely related (see next section) . It is likely that the two peptides we
copurify as LBP are both present in APRS and are not generated during
purification since immunoprecipitation of APRS also yields the two peptides .
The initial chromatographic step in this procedure, chromatography on Bio Rex-
70, provides a remarkable, nearly 1,000-fold purification ofLBP in a single step .
While the degree of purification of LBP is satisfactory, the yield of LBP activity79 0
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could be improved. Future development of an immunoassay for LBP will permit
consideration of whether the low yield of activity is due to loss or inactivation of
LBP, and should permit appropriate modifications to the purification procedure.
Our initial efforts to develop a purification of LBP provide some limits to
possible alternative purification schemes. Previous publications (1) from this
laboratory have described a method for the preparation of a euglobulin precip-
itate, which, when mixtures of LPS and APRS are used as the starting material,
results in removal of the ability of the serum to form C.1 .3. We assumed that
LBP would be found in this precipitate and we showed reconstitution of NRS
using the euglobulin precipitate. Ultimately, however, it was not possible to
prepare a stable form of LBP from this source. Additionally, LBP activity is not
recoverable from dextran or dextran/polyacrylamide gel filtration media.
Structural Properties of LBP.
￿
The two peptides that copurify as LBP have
identical partial amino acid sequences, although these are clearly separable by
SDS-PAGE. Whether the apparent size difference results from as yet unrevealed
differences in amino acid sequence or from differential glycosylation, and
whether the apparent size difference reflects any functional differences are all
questions that are not now answerable. Given the structural similarity between
the two peptides and their recovery in a somewhat variable ratio, it seems
unlikely that LBP in serum is a heterodimer of the peptides we purify.
The available amino acid sequence data, when tested for homology against a
wide variety of acute phase and normal proteins, do not reveal any clear
correlations. The significance of some homology between portions of LBP and
portions of human influenza virus b hemagglutinin precursor or baker's yeast
glyceraldehyde-3-phosphate dehydrogenase is unclear, since there are no obvious
functional similarities. Thus, although <5% of the sequence of LBP is available,
LBP does not appear to be homologous to any known normal or acute phase
protein.
In preliminary experiments, partial deglycosylation of LBP by peptide: N-
glycosidase F (Genzyme, Boston, MA) has been seen. The pattern of multiple
bands produced suggests a total of 3-4 carbohydrate chains of two different
types.
Functional Properties ofLBP.
￿
Experiments described earlier were designed to
test the hypothesis that LBP and LPS interact directly as the means by which
LBP exerts its effects. An alternate hypothesis was that in NRS, LPS uptake by
HDL requires an as yet unknown component X. Binding of LBP to Xcould then
block HDL uptake of LPS. The results clearly distinguish these two hypotheses.
If LBP interacted with X rather than LPS, immunoprecipitation of LBP would
coprecipitateX rather than LPS. Coprecipitation of LBP and LPS is the observed
result. Likewise, photolysis of ' 25I-ASD-LPS would not be expected to radiolabel
LBP if LBP were interacting with X rather than LPS. Thus we conclude that
LBP and LPS do directly interact.
Two sets of results argue that LBP is a component of C.1 .3 . In the first
instance, NRS can be endowed with the ability to form C.1 .3 by addition of
purified LBP. In the second instance, APRS can be made incompetent to form
C.1 .3 by immunoprecipitation of LBP. Consequently, one may conclude thatTOBIAS ET AL.
￿
79 1
LPSaggregates
LPSdisaggregrated + HDL
LBP
LPS-LBP ' '+HDL
(Complex 1 .3)
LPS-HDL
(Complex 1 .2)
-LBP
FIGURE 15.
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Schematic diagram of LPS interactions wtih HDL and LBP in serum.
C.1 .3 includes LBP and LPS in direct contact. If there are other components of
C.1 .3 they are not sufficiently bound to coimmunoprecipitate and they are not
acute phase reactants.
Fig. 15 summarizes our current understanding of the interactions of LPS with
HDL and LBP in serum. An initial disaggregation step (22) allows binding of
LPS to either LBP or HDL to form C .1 .3 or C .1 .2, respectively. However, since
the final state of LPS in serum is C.1 .2, C.1 .3 must also dissociate LPS. Whether
LPS transfers directly from LBP to HDL or goes via some other intermediate
form is unknown.
We speculate that LBP probably plays some role in modifying the endotoxic
effects of LPS. It is known that binding of LPS to HDL significantly alters the
endotoxic activity of LPS in at least three ways. First, the time course of
disappearance of a bolus dose of LPS from the circulation in vivo is biphasic
(23) ; uncomplexed LPS and HDL-complexed LPS are removed from plasma
with approximate t,, of 2 min and 12 h, respectively . Second, the endotoxic
activities of LPS and LPS-HDL complexes are different; the complexes are less
pyrogenic and less able to activate complement, but can still induce lethal
hypotensive shock and activate B cells and macrophages (24). The third conse-
quence of LPS-HDL complexation is the cellular targeting of LPS and LPS-HDL
complexes; stated simply, LPS itself is taken up by tissues containing macrophages
(23), whereas LPS-HDL complexes are taken up by tissues metabolizing choles-
terol, notably the adrenal gland (15). These observations underscore the point
that the biochemistry and endotoxic activity of LPS are subject to modification
by plasma proteins in important ways. Complexation of LPS to LBP provides a
mechanism to modulate the endotoxic properties of LPS in ways not previously
suspected.
With the benefit of hindsight, one might now say that several published studies
(25-27) indicate a role for acute phase reactants, and possibly for LBP, in
endotoxin tolerance or endotoxin inactivation. Since induction of tolerance
involves administration of sublethal doses of endotoxin and endotoxin is an
excellent acute phase inducer, induction of tolerance almost certainly also induces
acute phase reactants. The study of Filkins (27) clearly shows an LPS detoxifying
either of which induce an
acute phase response. It is intriguing to hypothesize that acute phase responses
to injury include a constitutive response to the potential dangers of gram-negative792
￿
LIPOPOLYSACCHARIDE-BINDING ACUTE PHASE REACTANT
infection . The studies described here provide the basis for further analysis of
this hypothesis .
Summary
This report describes the purification of an acute phase reactant from acute
phase rabbit serum, which endows normal serum with the properties of acute
phase serum, insofar as LPS is concerned. The acute phase reactant is referred
to as LPS-binding protein, or LBP. LBP was purified ^-2,000-fold by chromatog-
raphy of acute phase serum on Bio-Rex 70 and Mono-Q resins . The resulting
preparation consisted of two glycoproteins having molecular weights of 60,500
and 58,000 ; the two were obtained in a variable ratio, usually near 10:1,
respectively . After separation by SDS-PAGE, the N-terminal 36 amino acid
sequences of the two proteins were identical. From the N-terminal sequence, as
well as other properties of LBP, LBP appears to be unrelated to any known
acute phase reactants . The direct interaction ofLPS andLBP was inferred from
two types of evidence : first, immunoprecipitation of [3H]LPS from APRS by
anti-LBP sera ; and second, by the 1251-labeling of LBP when APRS-containing
'251-labeled 2-(p-azidosalicylamido)ethyl 1,3'-dithiopropionyl-LPS was photo-
lysed .
The data presented here support the concept that the 60-kD glycoprotein we
have termed LBP is a newly recognized acute phase reactant that may modulate
the biochemical and biologic properties of LPS in vivo .
Receivedfor publication 6 May 1986 .
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